Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study
Huiqiang Huang, Jun Zhu, Ming Yao, Tae Min Kim, Dok Hyun Yoon, Seok Goo Cho, Hyeon Seok Eom, Soon Thye Lim, Su peng Yeh, Yuqin Song, Yok Lam Kwong, Jin Seok Kim, Jie Jin, Yuankai Shi, Hye Jin Kim, Min Qing, Tianyuan Zhou, Grace Gao, Zongqi Dong, Ming QiWon Seog Kim
Research output: Contribution to journal › Article › peer-review
49Scopus
citations
Fingerprint
Dive into the research topics of 'Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study'. Together they form a unique fingerprint.